NTRK1 and bone neoplasm: The association of nerve growth factor with bone neoplasms is related to its high-affinity receptor TrkA, and the gene encoding TrkA, NTRK1, may undergo fusion mutations, resulting in sustained activation of downstream pathways (Yichao et al., 2024).